Silicon Valley Capital Partners’s Gilead Sciences GILD Stock Holding History

Silicon Valley Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.94K	Buy	+21	New	+$2.94K	﹤0.01%	269
2017 Q1	–	Sell	-12,443	Closed	-$891K	–	27
2016 Q4	$891K	Sell	12,443 -4,694	-27%	-$349K	0.6%	16
2016 Q3	$1.36M	Sell	17,137 -67	-0.4%	-$5.44K	1%	11
2016 Q2	$1.44M	Sell	17,204 -206	-1%	-$18.3K	1.11%	9
2016 Q1	$1.6M	Buy	+17,410	New	+$1.57M	1.29%	9

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Silicon Valley Capital Partners's GILD Position: Q1 2026 in Review

Silicon Valley Capital Partners opened a new position in Gilead Sciences (GILD) in Q1 2026: 21 shares worth $2.94K. The stake represents ﹤0.01% of the portfolio and ranks #269 among its holdings. This is a return to the name: Silicon Valley Capital Partners previously reported a position in GILD as recently as Q4 2016.

Silicon Valley Capital Partners first reported a position in GILD in Q1 2016 and has held it in 5 quarters since. The position peaked at $1.6M in Q1 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Silicon Valley Capital Partners held 21 shares of Gilead Sciences worth $2.94K as of Q1 2026.
Gilead Sciences was a new Silicon Valley Capital Partners position in Q1 2026.
Gilead Sciences made up ﹤0.01% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #269 holding.
Silicon Valley Capital Partners first reported a position in Gilead Sciences in Q1 2016 and has held it in 5 quarters since.
Silicon Valley Capital Partners's Gilead Sciences position peaked at $1.6M in Q1 2016.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.